Transchem

Transchem Pre-Tax Margin

The Pre-Tax Profit Margin of Transchem (500422.BO) as of Oct 21, 2026 is 268.51 %. In the previous year, Pre-Tax Profit Margin was 1,378.78 % — a change of -80.53% (lower).

Pre-Tax Margin

268.51 %

YoY

-80.53%

Last updated:

Pre-Tax Profit Margin of Transchem is 2025 268.51 % . Pre-Tax Profit Margin of Transchem was 2024 1,378.78 % . It decreases by -80.53% lower compared to the previous year.

The Transchem Pre-Tax Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Pre-Tax Margin
Date
Pre-Tax Margin
Jan 1, 2024
1,378.78 INR
Jan 1, 2025
268.51 INR
The Transchem Pre-Tax Margin history
YEARPre-Tax MarginYoY
268.51 %-80.53%
1,378.78 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Transchem Stock analysis

What does Transchem do? Transchem Ltd is a pharmaceutical company based in Thane, India, operating within the Health Care sector. The company has been publicly traded since its IPO on January 27, 1993, with a ticker symbol of 500422.BO and ISIN code INE019B01010. Its headquarters are located in Thane, Maharashtra. Transchem Ltd is engaged in the production and processing of pharmaceutical products, though specific product details are not provided. The company's website is https://www.transchem.net/. While the source description mentions the company's involvement in mushroom production, this appears to be an unverified or incorrect detail, as the company is classified under the Pharmaceuticals industry. The source also states that the company temporarily invests funds in short-term treasury operations while seeking new business opportunities, but this information should be treated with caution as it is not confirmed by official company sources. The company's primary focus remains on pharmaceutical manufacturing and processing within the Indian market. No additional details about its founding year, key personnel, acquisitions, or financial figures are provided in the available information. Transchem Ltd operates as a publicly listed entity on the Bombay Stock Exchange, though specific market capitalization or trading volume data is not included in the given facts. The company's activities are centered around pharmaceutical production, with no indication of other significant business lines beyond those related to the Health Care sector. Transchem is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Transchem stock

Pre-Tax Profit Margin of Transchem is 268.51 % in 2025.

Pre-Tax Profit Margin of Transchem changed from 1,378.78 % to 268.51 %, representing a -80.53% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Pre-Tax Profit Margin Transchem since 2006 – with annual values, charts, and detailed analysis.

Pre-tax margin measures the percentage of revenue remaining after all expenses except income taxes. It isolates operational and financial performance from tax effects.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Pre-Tax Profit Margin's Transchem with sector peers and the industry average to assess whether it is attractive.

To evaluate Pre-Tax Profit Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Pre-Tax Profit Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Margins — Transchem

Gross MarginEBIT MarginEBITDA MarginNet MarginFCF MarginR&D / RevenueTax RatePayout RatioPre-Tax MarginOCF MarginSGA/RevenueOpEx/RevenueReinvestment Rate

All Key Metrics — Transchem